New study aims to uncover clues to ovarian cancer survival

NCT ID NCT06969833

Recruiting now Knowledge-focused Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at 371 people with advanced ovarian, peritoneal, or fallopian tube cancer to find out what factors—like age, tumor type, and genetics—are linked to how long they live. Researchers will collect medical data and blood samples over two years. The goal is to build a database that helps doctors better predict outcomes and plan treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF THE FALLOPIAN TUBE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fallopian tube cancer fallopian tube carcinoma fallopian tube neoplasm ovarian cancer peritoneum cancer primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER OF THE FALLOPIAN TUBE CANCER OF THE OVARY PERITONEAL CANCER

Contacts and locations

Locations

Centre Oscar Lambret
RECRUITING

Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.